Valuation: Cegedim

Market Cap 15Cr 17Cr 14Cr 13Cr 24Cr 1.61TCr 25Cr 165.66Cr 64Cr 794.33Cr 64Cr 63Cr 2.76TCr P/E 2026 *
7.39x
P/E 2027 * 4.92x
Enterprise Value 33Cr 37Cr 30Cr 28Cr 53Cr 3.53TCr 54Cr 363.57Cr 140.36Cr 1.74TCr 140.36Cr 137.28Cr 6.05TCr EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.44x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.46%
1 week-4.28%
Current month-6.61%
1 month-5.37%
3 months+2.78%
6 months-20.15%
Current year-20.15%
1 week 10.74
Extreme 10.74
10.96
1 month 10.74
Extreme 10.74
11.38
Current year 8.7
Extreme 8.7
14.15
1 year 8.7
Extreme 8.7
14.15
3 years 8.7
Extreme 8.7
23.25
5 years 8.7
Extreme 8.7
29.9
10 years 8.7
Extreme 8.7
42.7
Manager TitleAgeSince
Chief Executive Officer 83 25/10/2009
Director of Finance/CFO - 14/06/2016
Corporate Officer/Principal 55 26/11/2015
Director TitleAgeSince
Chairman 83 25/10/2009
Director/Board Member 69 14/06/2016
Director/Board Member 72 09/08/2010
Change 5-day change 1-year change 3-year change Capi.($)
-1.29%-4.28% - - 17Cr
-0.52%-15.60%-29.72%+25.45% 43TCr
+1.11%+3.34%-47.04%+10.75% 18TCr
+1.66%+7.48%-51.11%-8.80% 10TCr
-1.85%+2.36%-44.50%+2.29% 4.12TCr
+12.60%-15.33%-75.86%+172.38% 3.26TCr
-0.45%+7.95%-35.17%+47.83% 2.73TCr
+3.99%+16.08%-35.84%+23.08% 1.63TCr
+0.14%+3.13%-32.89%-3.79% 1.18TCr
-0.50%+17.70%-48.65%+61.87% 1.01TCr
Average +0.52%+1.31%-44.53%+36.78% 9.45TCr
Weighted average by Cap. +0.17%-8.19%-39.07%+23.35%

Financials

2026 *2027 *
Net sales 66Cr 75Cr 61Cr 57Cr 107.17Cr 7.13TCr 109.62Cr 733.69Cr 283.24Cr 3.52TCr 283.25Cr 277.04Cr 12TCr 68Cr 78Cr 63Cr 59Cr 110.54Cr 7.36TCr 113.06Cr 756.74Cr 292.14Cr 3.63TCr 292.15Cr 285.74Cr 13TCr
Net income 2.12Cr 2.43Cr 1.96Cr 1.83Cr 3.45Cr 229.45Cr 3.53Cr 24Cr 9.11Cr 113.2Cr 9.11Cr 8.91Cr 393Cr 3.06Cr 3.49Cr 2.82Cr 2.64Cr 4.96Cr 330.22Cr 5.08Cr 34Cr 13Cr 162.91Cr 13Cr 13Cr 565.6Cr
Net Debt 18Cr 20Cr 16Cr 15Cr 29Cr 1.92TCr 30Cr 197.91Cr 76Cr 948.98Cr 76Cr 75Cr 3.29TCr 15Cr 17Cr 14Cr 13Cr 24Cr 1.62TCr 25Cr 166.36Cr 64Cr 797.7Cr 64Cr 63Cr 2.77TCr
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
6,344
Date Price Change
30/26/30 10.74 -1.29%
29/26/29 €10.88 -0.18%
26/26/26 €10.90 +0.18%
25/26/25 €10.88 -0.73%
24/26/24 €10.96 -2.32%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
10.86EUR
Average target price
15.00EUR
Spread / Average Target
+38.12%

Quarterly revenue - Rate of surprise